Analysts' ratings for Tango Therapeutics (NASDAQ:TNGX) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
2
0
0
0
Last 30D
0
1
0
0
0
1M Ago
1
1
0
0
0
2M Ago
0
0
0
0
0
3M Ago
1
0
0
0
0
In the assessment of 12-month price targets, analysts unveil insights for Tango Therapeutics, presenting an average target of $14.5, a high estimate of $17.00, and a low estimate of $11.00. A decline of 16.33% from the prior average price target is evident in the current average.
Understanding Analyst Ratings: A Comprehensive Breakdown
The perception of Tango Therapeutics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Peter Lawson
Barclays
Lowers
Overweight
$13.00
$18.00
Robert Driscoll
Wedbush
Lowers
Outperform
$11.00
$18.00
Robert Burns
HC Wainwright & Co.
Maintains
Buy
$17.00
-
Robert Burns
HC Wainwright & Co.
Raises
Buy
$17.00
$16.00
Key Insights:
Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Tango ...Full story available on Benzinga.com
Benzinga
